Alopecia areata: an autoimmune disease?

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 10536963)

Published in Exp Dermatol on October 01, 1999

Authors

K J McElwee1, D J Tobin, J C Bystryn, L E King, J P Sundberg

Author Affiliations

1: The Jackson Laboratory, Bar Harbor, Maine, USA.

Articles by these authors

Notch signaling is essential for vascular morphogenesis in mice. Genes Dev (2000) 6.88

CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med (1998) 3.01

Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol (1998) 2.76

Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol (1987) 2.51

Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30

Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest (2000) 2.21

The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol (1998) 2.13

Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun (2007) 2.05

Immunofluorescence abnormalities in lichen planopilaris. Arch Dermatol (1992) 2.02

An invasive spirochaete associated with interdigital papillomatosis of dairy cattle. Vet Rec (1992) 1.90

Lesions of aryl-hydrocarbon receptor-deficient mice. Vet Pathol (1997) 1.85

Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet (1999) 1.84

Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol (1994) 1.78

The visualization of human erythrocyte membrane proteins and glycoproteins in SDS polyacrylamide gels employing a single staining procedure. Anal Biochem (1976) 1.72

Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med (1970) 1.70

Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol (1997) 1.69

Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol (2000) 1.69

Web-based access to mouse models of human cancers: the Mouse Tumor Biology (MTB) Database. Nucleic Acids Res (2001) 1.68

Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med (1987) 1.66

What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65

Pathbase and the MPATH ontology. Community resources for mouse histopathology. Vet Pathol (2010) 1.64

Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology (1994) 1.63

Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol (1997) 1.62

Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60

In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc (1999) 1.58

Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J Infect Dis (1990) 1.57

Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol (1986) 1.56

Antibodies to normal human melanocytes in vitiligo. J Exp Med (1983) 1.50

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol (1992) 1.48

Mercury exposure and cutaneous disease. J Am Acad Dermatol (2000) 1.47

Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol (1998) 1.46

The dynamic link between the integrity of the immune system and zinc status. J Nutr (2000) 1.45

The Mouse Tumor Biology Database (MTB): a central electronic resource for locating and integrating mouse tumor pathology data. Vet Pathol (2011) 1.44

The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42

The North American experience with photopheresis. Ther Apher (1999) 1.42

Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol (2000) 1.42

Role of epidermal growth factor in carcinogenesis. Cancer Res (1986) 1.41

Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles. Genes Dev (1993) 1.40

Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res (1991) 1.40

An evaluation of the accuracy of residency applicants' curricula vitae: are the claims of publications erroneous? J Am Acad Dermatol (1996) 1.40

The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38

Association of tissue-fixed cytoplasmic deposits of immunoglobulin in epidermal keratinocytes with lupus erythematosus. Arch Dermatol (1993) 1.38

Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics (2001) 1.38

Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods (1994) 1.36

Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen. J Invest Dermatol (1990) 1.36

Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ (1993) 1.33

Trichodysplasia spinulosa--a newly described folliculocentric viral infection in an immunocompromised host. J Investig Dermatol Symp Proc (1999) 1.33

Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol (1998) 1.33

Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans. Vet Pathol (2010) 1.32

Characterization by electrophoresis of epidermal growth factor stimulated phosphorylation using A-431 membranes. Biochemistry (1980) 1.31

A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A (2001) 1.30

Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics (1999) 1.29

Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol (2000) 1.29

What is the 'true' function of skin? Exp Dermatol (2002) 1.26

Management of alopecia areata. BMJ (2010) 1.25

Corn1: a mouse model for corneal surface disease and neovascularization. Invest Ophthalmol Vis Sci (1996) 1.24

Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J Immunol (1999) 1.23

Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol (1990) 1.23

Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells. Exp Cell Res (2001) 1.21

Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol (1995) 1.21

Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol (1981) 1.21

Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. JAMA (1988) 1.21

Identification of the substance binding pemphigus antibody and concanavalin A in the skin. J Invest Dermatol (1974) 1.20

Pemphigus foliaceus. Subcorneal intercellular antibodies of unique specificity. Arch Dermatol (1974) 1.20

Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus. Exp Mol Pathol (2000) 1.20

Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol (1990) 1.19

Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology (1993) 1.17

Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm Bowel Dis (2000) 1.17

Mice mutant for Ppap2c, a homolog of the germ cell migration regulator wunen, are viable and fertile. Genesis (2000) 1.16

Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol (1991) 1.15

A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology (1994) 1.15

A data-capture tool for mouse pathology phenotyping. Vet Pathol (2009) 1.14

What causes alopecia areata? Exp Dermatol (2013) 1.14

Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol (1984) 1.14

Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology (1998) 1.14

Antibodies to hair follicles in alopecia areata. J Invest Dermatol (1994) 1.13

Novel laboratory mouse papillomavirus (MusPV) infection. Vet Pathol (2010) 1.13

Necrotic arachnidism. J Am Acad Dermatol (2001) 1.13

Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13

Sepcific removal of in vivo antibody by extracorporeal circulation over an immunoadsorbent in gel. J Clin Invest (1971) 1.13

Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol (1995) 1.12

Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12. Eur J Immunol (2001) 1.12

Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol (1996) 1.12

Nineteen documented cases of Loxosceles reclusa envenomation. J Am Acad Dermatol (2001) 1.12

Cloning and characterization of a canine oral papillomavirus. Am J Vet Res (1986) 1.11

Cutaneous papillomas associated with a herpesvirus-like infection in a herd of captive African elephants. J Am Vet Med Assoc (1986) 1.10

Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol (2006) 1.10

Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann N Y Acad Sci (1998) 1.09

Salmonellosis in reptiles: a review. Am J Epidemiol (1981) 1.09

Expression of terminal differentiation proteins defines stages of mouse mammary gland development. Vet Pathol (2006) 1.09

Absence of intercellular antigens in the deep layers of the epidermis in pemphigus foliaceus. J Clin Invest (1978) 1.08

Mouse tumor biology database (MTB): enhancements and current status. Nucleic Acids Res (2000) 1.08

Calcium effects on human erythrocyte membrane proteins. Biochim Biophys Acta (1977) 1.07